Anti-alpha + beta Synuclein 抗体 [EP1646Y] (ab51252)

ab51252 は 10 報の論文で使用されています。

• Binolfi A  et al. Intracellular repair of oxidation-damaged a-synuclein fails to target C-terminal modification sites. Nat Commun 7:10251 (2016). WB, ICC/IF . PubMed: 26807843
• Woulfe J  et al. Human serum antibodies against EBV latent membrane protein 1 cross-react with a-synuclein. Neurol Neuroimmunol Neuroinflamm 3:e239 (2016). WB ; Human . PubMed: 27218119
• Moscovitz O  et al. The Parkinson's-associated protein DJ-1 regulates the 20S proteasome. Nat Commun 6:6609 (2015). WB . PubMed: 25833141
• Ambrosi G  et al. Bioenergetic and proteolytic defects in fibroblasts from patients with sporadic Parkinson's disease. Biochim Biophys Acta 1842:1385-94 (2014). PubMed: 24854107
• Hall H  et al. Characterization of cognitive deficits in rats overexpressing human alpha-synuclein in the ventral tegmental area and medial septum using recombinant adeno-associated viral vectors. PLoS One 8:e64844 (2013). PubMed: 23705016
• Ejlerskov P  et al. Tubulin polymerization-promoting protein (TPPP/p25a) promotes unconventional secretion of a-synuclein through exophagy by impairing autophagosome-lysosome fusion. J Biol Chem 288:17313-35 (2013). PubMed: 23629650
• Hejjaoui M  et al. Elucidating the role of C-terminal post-translational modifications using protein semisynthesis strategies: a-synuclein phosphorylation at tyrosine 125. J Am Chem Soc 134:5196-210 (2012). WB, ICC/IF . PubMed: 22339654
• Binolfi A  et al. Bacterial in-cell NMR of human a-synuclein: a disordered monomer by nature? Biochem Soc Trans 40:950-4 (2012). WB . PubMed: 22988846
• Li J  et al. Neuromelanin enhances the toxicity of a-synuclein in SK-N-SH cells. J Neural Transm 119:685-91 (2012). WB . PubMed: 22200858
• Qing H  et al. Lrrk2 phosphorylates alpha synuclein at serine 129: Parkinson disease implications. Biochem Biophys Res Commun 387:149-52 (2009). PubMed: 19576176